Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

Impact of malnutrition on clinical presentation, clinical course, and mortality in MDR-TB patients.

Podewils LJ, Holtz T, Riekstina V, Skripconoka V, Zarovska E, Kirvelaite G, Kreigere E, Leimane V.

Epidemiol Infect. 2011 Jan;139(1):113-20. doi: 10.1017/S0950268810000907. Epub 2010 Apr 30.

PMID:
20429966
[PubMed - indexed for MEDLINE]
2.

Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.

Kim HR, Hwang SS, Kim HJ, Lee SM, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ.

Clin Infect Dis. 2007 Nov 15;45(10):1290-5. Epub 2007 Oct 15.

PMID:
17968823
[PubMed - indexed for MEDLINE]
Free Article
3.

Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK.

Melzer M, Gupta N, Petersen I, Cook S, Hall B.

Int J Infect Dis. 2010 Aug;14(8):e717-22. doi: 10.1016/j.ijid.2010.02.2247. Epub 2010 Jun 12.

PMID:
20542460
[PubMed - indexed for MEDLINE]
Free Article
4.

Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.

Reechaipichitkul W.

Southeast Asian J Trop Med Public Health. 2002 Sep;33(3):570-4.

PMID:
12693593
[PubMed - indexed for MEDLINE]
5.

Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients.

Pawar UM, Kundnani V, Agashe V, Nene A, Nene A.

Spine (Phila Pa 1976). 2009 Oct 15;34(22):E806-10. doi: 10.1097/BRS.0b013e3181af7797.

PMID:
19829244
[PubMed - indexed for MEDLINE]
6.

Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.

Clin Infect Dis. 2008 Aug 15;47(4):496-502. doi: 10.1086/590005.

PMID:
18611154
[PubMed - indexed for MEDLINE]
Free Article
7.

Adverse events related to multidrug-resistant tuberculosis treatment, Latvia, 2000-2004.

Bloss E, Kuksa L, Holtz TH, Riekstina V, Skripconoka V, Kammerer S, Leimane V.

Int J Tuberc Lung Dis. 2010 Mar;14(3):275-81.

PMID:
20132617
[PubMed - indexed for MEDLINE]
8.

An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993.

Chum HJ, O'Brien RJ, Chonde TM, Graf P, Rieder HL.

AIDS. 1996 Mar;10(3):299-309.

PMID:
8882670
[PubMed - indexed for MEDLINE]
9.

Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines.

Mendoza MT, Gonzaga AJ, Roa C, Velmonte MA, Jorge M, Montoya JC, Tan Torres T, Ong M, Barez MY, Ang CF.

Int J Tuberc Lung Dis. 1997 Feb;1(1):59-63.

PMID:
9441060
[PubMed - indexed for MEDLINE]
10.

Prevalence of multidrug-resistant pulmonary tuberculosis in counties with different duration of DOTS implementation in rural China.

Hu Y, Mathema B, Wang W, Hoffner S, Kreiswirth B, Xu B.

Microb Drug Resist. 2008 Sep;14(3):227-32. doi: 10.1089/mdr.2008.0823.

PMID:
18707239
[PubMed - indexed for MEDLINE]
11.

Clinical outcomes of Estonian patients with primary multidrug-resistant versus drug-susceptible tuberculosis.

Lockman S, Kruuner A, Binkin N, Levina K, Wang Y, Danilovitsh M, Hoffner S, Tappero J.

Clin Infect Dis. 2001 Feb 1;32(3):373-80. Epub 2001 Jan 26.

PMID:
11170944
[PubMed - indexed for MEDLINE]
Free Article
12.

Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995.

Liu Z, Shilkret KL, Finelli L.

Int J Epidemiol. 1998 Feb;27(1):121-6.

PMID:
9563705
[PubMed - indexed for MEDLINE]
Free Article
13.
14.

Risk factors for drug resistant tuberculosis in southeast Turkey.

Tanrikulu AC, Hosoglu S, Ozekinci T, Abakay A, Gurkan F.

Trop Doct. 2008 Apr;38(2):91-3. doi: 10.1258/td.2007.070131.

PMID:
18453496
[PubMed - indexed for MEDLINE]
15.

Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.

Mannheimer SB, Sepkowitz KA, Stoeckle M, Friedman CR, Hafner A, Riley LW.

Int J Tuberc Lung Dis. 1997 Aug;1(4):319-25.

PMID:
9432387
[PubMed - indexed for MEDLINE]
16.

Drug-resistant tuberculosis in six hospitals in Rio de Janeiro, Brazil.

Brito RC, Mello FC, Andrade MK, Oliveira H, Costa W, Matos HJ, Lourenço MC, Rolla VC, Fonseca L, Ruffino Netto A, Kritski AL.

Int J Tuberc Lung Dis. 2010 Jan;14(1):24-33.

PMID:
20003691
[PubMed - indexed for MEDLINE]
17.

Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran.

Baghaei P, Tabarsi P, Dorriz D, Marjani M, Shamaei M, Pooramiri MV, Mansouri D, Farnia P, Masjedi M, Velayati A.

Am J Ther. 2011 Mar-Apr;18(2):e29-34. doi: 10.1097/MJT.0b013e3181c0806d.

PMID:
20019591
[PubMed - indexed for MEDLINE]
18.

Risk factors for multidrug-resistant tuberculosis in Hong Kong.

Law WS, Yew WW, Chiu Leung C, Kam KM, Tam CM, Chan CK, Leung CC.

Int J Tuberc Lung Dis. 2008 Sep;12(9):1065-70.

PMID:
18713506
[PubMed - indexed for MEDLINE]
19.

Predictors and mortality associated with treatment default in pulmonary tuberculosis.

Kliiman K, Altraja A.

Int J Tuberc Lung Dis. 2010 Apr;14(4):454-63.

PMID:
20202304
[PubMed - indexed for MEDLINE]
20.

Recent nosocomial transmission and genotypes of multidrug-resistant Mycobacterium tuberculosis.

Nodieva A, Jansone I, Broka L, Pole I, Skenders G, Baumanis V.

Int J Tuberc Lung Dis. 2010 Apr;14(4):427-33.

PMID:
20202300
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk